Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives

References

• Friedman JF, Olveda RM, Mirochnick MH, Bustinduy AL, Elliott AM. World health assembly. Bull World Health Organ. 2018;96:59–65. doi:10.2471/BLT.17.19887929403101
   PubMed Web of Science ®Google Scholar
• Rollinson D, Knopp S, Levitz S, et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128(2):423–440. doi:10.1016/j.actatropica.2012.04.01322580511
   PubMed Web of Science ®Google Scholar
• Booth M, Vennervald BJ, Kabatereine NB, et al. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence. Trans R Soc Trop Med Hyg. 2004;98(2):125–136. doi:10.1016/s0035-9203(03)00018-x14964813
   PubMed Web of Science ®Google Scholar
• Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis. 2007;7(3):218–224. doi:10.1016/S1473-3099(07)70053-117317603
   PubMed Web of Science ®Google Scholar
• King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008;4(1):65–79. doi:10.1177/174239530708440718322031
   PubMedGoogle Scholar
• Gasim GI, Bella A, Adam I. Schistosomiasis, hepatitis B and hepatitis C co-infection. Virol J. 2015;12:19. doi:10.1186/s12985-015-0251-225889398
   PubMed Web of Science ®Google Scholar
• van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem. 2002;277(50):48122–48129. doi:10.1074/jbc.M20694120012359728
   PubMed Web of Science ®Google Scholar
• Elbaz T, Esmat G. Hepatic and intestinal schistosomiasis: review. J Adv Res. 2013;4(5):445–452. doi:10.1016/j.jare.2012.12.00125685451
   PubMedGoogle Scholar
• Wang B, Liang S, Wang Y, et al. Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice. PLoS Negl Trop Dis. 2015;9(1):e0003434. doi:10.1371/journal.pntd.000343425590646
   PubMed Web of Science ®Google Scholar
• Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, McManus DP. Immunopathogenesis of human schistosomiasis. Parasite Immunol. 2009;31(4):163–176. doi:10.1111/j.1365-3024.2009.01098.x19292768
   PubMed Web of Science ®Google Scholar
• Colley DG, Secor WE. Immunology of human schistosomiasis. Parasite Immunol. 2014;36(8):347–357. doi:10.1111/pim.1208725142505
   PubMed Web of Science ®Google Scholar
• Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev. 2004;201:156–167. doi:10.1111/j.0105-2896.2004.00176.x15361239
   PubMed Web of Science ®Google Scholar
• Morais CN, Souza JR, Melo WG, et al. Cytokine profile associated with chronic and acute human schistosomiasis mansoni. Mem Inst Oswaldo Cruz. 2008;103(6):561–568. doi:10.1590/s0074-0276200800060000918949326
   PubMed Web of Science ®Google Scholar
• Gieseck RL 3rd, Ramalingam TR, Hart KM, et al. Interleukin-13 activates distinct cellular pathways leading to ductular reaction, steatosis, and fibrosis. Immunity. 2016;45(1):145–158. doi:10.1016/j.immuni.2016.06.00927421703
   PubMed Web of Science ®Google Scholar
• Borthwick LA, Barron L, Hart KM, et al. Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol. 2016;9(1):38–55. doi:10.1038/mi.2015.3425921340
   PubMed Web of Science ®Google Scholar
• Lewis FA, Tucker MS. Schistosomiasis advances in experimental medicine and biology. Adv Exp Med Biol. 2014;766:47–75. doi:10.1007/978-1-4939-0915-5_324903363
   PubMed Web of Science ®Google Scholar
• Stadecker MJ, Asahi H, Finger E, Hernandez HJ, Rutitzky LI, Sun J. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev. 2004;201:168–179. doi:10.1111/j.0105-2896.2004.00197.x15361240
   PubMed Web of Science ®Google Scholar
• Shaker Y, Samy N, Ashour E. Hepatobiliary Schistosomiasis. J Clin Transl Hepatol. 2014;2(3):212–216. doi:10.14218/JCTH.2014.0001826357627
   PubMedGoogle Scholar
• Andrade ZA, Santana TS. Angiogenesis and schistosomiasis. Mem Inst Oswaldo Cruz. 2010;105(4):436–439. doi:10.1590/s0074-0276201000040001320721486
   PubMed Web of Science ®Google Scholar
• Baptista AP, Andrade ZA. Angiogenesis and schistosomal granuloma formation. Mem Inst Oswaldo Cruz. 2005;100(2):183–185. doi:10.1590/s0074-0276200500020001216021306
   PubMed Web of Science ®Google Scholar
• Dematei A, Fernandes R, Soares R, Alves H, Richter J, Botelho MC. Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer APMIS : acta pathologica. microbiologica, et immunologica Scandinavica. 2017;125(12):1056–1062. doi:10.1111/apm.12756
   Web of Science ®Google Scholar
• Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–1342. doi:10.1002/hep.2614123172780
   PubMed Web of Science ®Google Scholar
• Omar HH, Taha SA, Hassan WH, Omar HH. Impact of schistosomiasis on increase incidence of occult hepatitis B in chronic hepatitis C patients in Egypt. J Infect Public Health. 2017;10(6):761–765. doi:10.1016/j.jiph.2016.11.01028196636
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman M, El-Sayed M, El Raziky M, et al. Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. World J Gastroenterol. 2013;19(17):2691–2696. doi:10.3748/wjg.v19.i17.269123674877
   PubMed Web of Science ®Google Scholar
• Abruzzi A, Fried B, Alikhan SB. Coinfection of Schistosoma species with Hepatitis B or Hepatitis C viruses. Adv Parasitol. 2016;91:111–231. doi:10.1016/bs.apar.2015.12.00327015949
   PubMed Web of Science ®Google Scholar
• Mazigo HD, Kepha S, Kaatano GM, Kinung’hi SM. Co-infection of Schistosoma mansoni/hepatitis C virus and their associated factors among adult individuals living in fishing villages, north-western Tanzania. BMC Infect Dis. 2017;17(1):668. doi:10.1186/s12879-017-2757-229017483
   PubMed Web of Science ®Google Scholar
• Du H. [Relationship between advanced schistosomiasis and HBV infection]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2013;25(1):115,7.23687837
   PubMedGoogle Scholar
• Muller CP, Edris A, Nour MO, et al. Seroprevalence and risk factors for hepatitis B and C virus infection in Damietta Governorate, Egypt. PloS One. 2014;20(10):605–613.
   Google Scholar
• Xaydalasouk K, Strobel M, Buisson Y, Black AP. Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factories. PLoS One. 2018;13(7):e0199919.30011282
   PubMed Web of Science ®Google Scholar
• Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020–1026. doi:10.1016/j.cmi.2015.06.02826163105
   PubMed Web of Science ®Google Scholar
• Edwards MJ, Buchatska O, Ashton M, Montoya M, Bickle QD, Borrow P. Reciprocal immunomodulation in a schistosome and hepatotropic virus coinfection model. J Immunol. 2005;175(10):6275–6285. doi:10.4049/jimmunol.175.10.627516272278
   PubMed Web of Science ®Google Scholar
• Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):47–52. doi:10.7150/ijms.3.4716614742
   PubMedGoogle Scholar
• Kamal SM, Rasenack JW, Bianchi L, et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology. 2001;121(3):646–656. doi:10.1053/gast.2001.2702411522749
   PubMed Web of Science ®Google Scholar
• Makhlouf LM, Serwah Ael H, Abd El-Hamid Ael D, Hussein EM, Saad RM. INF-gamma, IL-5 and IgE profiles in chronic schistosomiasis mansoni Egyptian patients with or without hepatitis C infection. J Egypt Soc Parasitol. 2006;36(1):177–196.16605110
   PubMedGoogle Scholar
• Elrefaei M, El-Sheikh N, Kamal K, Cao H. HCV-specific CD27- CD28- memory T cells are depleted in hepatitis C virus and Schistosoma mansoni co-infection. Immunology. 2003;110(4):513–518. doi:10.1111/j.1365-2567.2003.01769.x14632650
   PubMed Web of Science ®Google Scholar
• Emam EA, Emam M, Shehata AE, Emara M. Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection. Egypt J Immunol. 2006;13(2):33–40.18689269
   PubMedGoogle Scholar
• Van-Lume DS, de Albuquerque MF, Souza AI, et al. Association between Schistosomiasis mansoni and hepatitis C: systematic review. Rev Saude Publica. 2013;47(2):414–424. doi:10.1590/S0034-910.201304700424724037369
   PubMed Web of Science ®Google Scholar
• Ashir GM, Rabasa AI, Gofama MM, Bukbuk D, Abubakar H, Farouk GA. Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection. Niger J Med. 2009;18(3):260–262.20120641
   PubMedGoogle Scholar
• McClary H, Koch R, Chisari FV, Guidotti LG. Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice. J Exp Med. 2000;192(2):289–294. doi:10.1084/jem.192.2.28910899915
   PubMed Web of Science ®Google Scholar
• Andrade JR, Silva LD, Guimaraes CM, et al. Chronic hepatitis B and liver schistosomiasis: a deleterious association. Trans R Soc Trop Med Hyg. 2014;108(3):159–164. doi:10.1093/trstmh/tru01024535152
   PubMed Web of Science ®Google Scholar
• Mohamed A, Elsheikh A, Ghandour Z, Al Karawi M. Impact of hepatitis C virus infection on schistosomal liver disease. Hepatogastroenterology. 1998;45(23):1492–1496.9840092
   PubMed Web of Science ®Google Scholar
• Bahgat MM. Interaction between the neglected tropical disease human schistosomiasis and HCV infection in Egypt: a puzzling relationship. J Clin Transl Hepatol. 2014;2(2):134–139. doi:10.14218/JCTH.2013.0002826356794
   PubMedGoogle Scholar
• Gad A, Tanaka E, Orii K, et al. Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect. J Gastroenterol. 2001;36(11):753–758.11757747
   PubMed Web of Science ®Google Scholar
• Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology. 2004;126(4):1024–1029. doi:10.1053/j.gastro.2004.01.01115057742
   PubMed Web of Science ®Google Scholar
• Liu CJ, Chuang WL, Lee CM, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology. 2009;136(2):496–504.e3. doi:10.1053/j.gastro.2008.10.04919084016
   PubMed Web of Science ®Google Scholar
• Lee LP, Dai CY, Chuang WL, et al. Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients. J Gastroenterol Hepatol. 2007;22(4):515–517. doi:10.1111/j.1440-1746.2006.04547.x17376043
   PubMed Web of Science ®Google Scholar
• Liu CJ, Liou JM, Chen DS, Chen PJ. Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections. J Formos Med Assoc. 2005;104(11):783–791.16496056
   PubMed Web of Science ®Google Scholar
• Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis. 1990;162(4):817–822. doi:10.1093/infdis/162.4.8172169497
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and “silent” HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol. 2001;64(3):350–355.11424125
   PubMed Web of Science ®Google Scholar
• Zampino R, Pisaturo MA, Cirillo G, et al. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration. Ann Hepatol. 2015;14(1):75–82.25536644
   PubMed Web of Science ®Google Scholar
• Lundy SK, Lukacs NW. Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Front Immunol. 2013;4:39. doi:10.3389/fimmu.2013.0003923429492
   PubMed Web of Science ®Google Scholar